TGTX Free Cash Flow Growth
Tg Therapeutics Inc · Free Cash Flow Growth
TGTX Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported129.35%period ending
TGTX TTM Free Cash Flow YoY % (28.95% → 129.35%)
Year-over-year change
High-resolution chart · PNG
TGTX free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 129.3482% | |
| 76.7722% | |
| 38.4005% | |
| -149.879% | |
| -187.3406% | |
| -401.2277% | |
| -29.1249% | |
| 33.1923% | |
| 142.3156% | |
| 112.1166% | |
| 82.1703% | |
| 82.417% | |
| 41.0914% | |
| 40.9161% | |
| 40.4854% | |
| 8.3938% | |
| -8.5857% | |
| -21.019% | |
| -37.7779% | |
| -35.2737% | |
| -47.6048% | |
| -44.7269% | |
| -61.6284% | |
| -41.7779% | |
| -24.8445% | |
| -20.4314% | |
| -3.04% | |
| -16.2424% | |
| -27.1788% | |
| -34.947% | |
| -37.5932% | |
| -31.7207% | |
| -31.6125% | |
| -47.9302% | |
| -51.3927% | |
| -53.976% | |
| -52.0818% | |
| -27.4301% | |
| -38.4571% | |
| -23.0002% | |
| -20.51% | |
| -48.1635% | |
| -27.5211% | |
| -88.8688% | |
| -146.6266% | |
| -110.1504% | |
| -223.9037% | |
| -268.3366% | |
| -109.24% | |
| -159.5833% | |
| -108.6944% | |
| -57.8896% | |
| -449.4583% | |
| -462.7279% | |
| -5,893.9279% | |
| -506.3092% | |
| -86.5901% | |
| -0.7132% | |
| 95.6055% | |
| 59.8895% | |
| 43.6422% | |
| -14.255% | |
| -87.6657% | |
| -7.0581% | |
| 29.9378% | |
| 72.1946% | |
| 76.4105% | |
| 66.5727% | |
| 69.9005% | |
| 61.8864% | |
| 56.5354% | |
| 52.0417% | |
| 26.7383% | |
| -16.2126% | |
| -31.473% | |
| -20.8589% | |
| -23.8245% | |
| -21% | |
| -23.9207% | |
| -36.5485% | |
| -24.7304% | |
| -16.4587% | |
| -7.8183% | |
| -12.0233% | |
| -34.8908% | |
| -37.6479% | |
| -68.5556% | |
| -176.7579% | |
| -198.5582% | |
| -209.3783% | |
| -140.9247% | |
| -1.9268% | |
| 37.7417% | |
| 50.1434% | |
| 68.6787% | |
| 15.2765% | |
| -1.4049% | |
| 18.4929% | |
| -246.0149% | |
| 22.6946% |